WO2018199530A3 - 대사체 분석을 이용한 베체트병의 진단방법 - Google Patents
대사체 분석을 이용한 베체트병의 진단방법 Download PDFInfo
- Publication number
- WO2018199530A3 WO2018199530A3 PCT/KR2018/004417 KR2018004417W WO2018199530A3 WO 2018199530 A3 WO2018199530 A3 WO 2018199530A3 KR 2018004417 W KR2018004417 W KR 2018004417W WO 2018199530 A3 WO2018199530 A3 WO 2018199530A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- behcet
- disease
- diagnostic method
- metabolome analysis
- metabolome
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7206—Mass spectrometers interfaced to gas chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8822—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/328—Vasculitis, i.e. inflammation of blood vessels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7095—Inflammation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
본 발명은 대사체 분석을 이용한 베체트병 진단방법에 관한 것으로, 대사체학을 이용하여 베체트병을 효과적으로 진단할 수 있는 바이오마커를 제공하며, 이는 베체트병 치료제 개발에도 적용할 수 있다.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201880027141.9A CN110546505A (zh) | 2017-04-25 | 2018-04-17 | 利用代谢组分析诊断白塞氏病的方法 |
JP2019557367A JP7179356B2 (ja) | 2017-04-25 | 2018-04-17 | 代謝物分析を利用したベーチェット病の診断方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0052665 | 2017-04-25 | ||
KR1020170052665A KR101946884B1 (ko) | 2017-04-25 | 2017-04-25 | 대사체 분석을 이용한 베체트병의 진단방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018199530A2 WO2018199530A2 (ko) | 2018-11-01 |
WO2018199530A3 true WO2018199530A3 (ko) | 2019-01-10 |
Family
ID=63920311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/004417 WO2018199530A2 (ko) | 2017-04-25 | 2018-04-17 | 대사체 분석을 이용한 베체트병의 진단방법 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7179356B2 (ko) |
KR (1) | KR101946884B1 (ko) |
CN (1) | CN110546505A (ko) |
WO (1) | WO2018199530A2 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102094802B1 (ko) * | 2017-10-24 | 2020-03-31 | 고려대학교 산학협력단 | 소변 대사체 분석을 이용한 베체트병의 진단방법 |
KR102150837B1 (ko) * | 2019-02-22 | 2020-09-03 | 고려대학교 산학협력단 | 소변의 대사체 분석을 위한 소변 샘플 처리 방법 |
KR102355568B1 (ko) * | 2020-07-20 | 2022-02-07 | 연세대학교 산학협력단 | 베체트 장염의 진단용 바이오마커 |
CN112881668B (zh) * | 2021-01-18 | 2022-04-12 | 江苏省中医院 | 两种血清代谢物单独或联合用于制备诊断干燥综合征的试剂盒的用途 |
CN113539478B (zh) * | 2021-06-24 | 2023-04-07 | 山西医科大学 | 基于代谢组学的深静脉血栓形成预测模型的建立方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101516086B1 (ko) * | 2013-10-25 | 2015-05-07 | 고려대학교 산학협력단 | 대사체 분석을 이용한 류마티스 관절염 진단방법 |
KR20150146032A (ko) * | 2014-06-20 | 2015-12-31 | 고려대학교 산학협력단 | 혐기성 균의 대사체 분석을 위한 대사체 샘플링 및 처리 방법 |
KR20160141140A (ko) * | 2015-05-28 | 2016-12-08 | 고려대학교 산학협력단 | 대사체 분석을 이용한 베체트병 관절염의 진단방법 |
KR20160148807A (ko) * | 2015-06-16 | 2016-12-27 | 연세대학교 산학협력단 | 장 베체트병 진단용 바이오마커 및 이의 용도 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100448488B1 (ko) | 2001-09-03 | 2004-09-13 | (주)프로테옴텍 | 베체트병의 질병 표시인자로서의 아포리포프로테인에이-1을 이용한 진단 시스템 |
PL213925B1 (pl) | 2002-07-19 | 2013-05-31 | Abbott Biotech Ltd | Przeciwcialo anty-TNFα lub jego czesc wiazaca antygen, ich zastosowanie oraz zestaw |
JP2006180704A (ja) | 2003-03-05 | 2006-07-13 | Senju Pharmaceut Co Ltd | 新規タンパクおよびその用途 |
JP5781764B2 (ja) | 2007-11-27 | 2015-09-24 | ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア | 14−3−3η抗体、並びに関節炎の診断及び治療のためのその使用 |
JP2016070798A (ja) | 2014-09-30 | 2016-05-09 | 学校法人 埼玉医科大学 | ベーチェット病の判定を補助する方法、及びベーチェット病の活動性の評価を補助する方法 |
KR101568632B1 (ko) * | 2015-03-02 | 2015-11-11 | 연세대학교 산학협력단 | Hsc71 단백질에 대한 항체를 포함하는 베체트병 진단 키트 |
WO2017040464A1 (en) | 2015-08-31 | 2017-03-09 | Merck Patent Gmbh | Methods for the modulation of lgals3bp to treat systemic lupus erythematosus |
-
2017
- 2017-04-25 KR KR1020170052665A patent/KR101946884B1/ko active IP Right Grant
-
2018
- 2018-04-17 CN CN201880027141.9A patent/CN110546505A/zh active Pending
- 2018-04-17 WO PCT/KR2018/004417 patent/WO2018199530A2/ko active Application Filing
- 2018-04-17 JP JP2019557367A patent/JP7179356B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101516086B1 (ko) * | 2013-10-25 | 2015-05-07 | 고려대학교 산학협력단 | 대사체 분석을 이용한 류마티스 관절염 진단방법 |
KR20150146032A (ko) * | 2014-06-20 | 2015-12-31 | 고려대학교 산학협력단 | 혐기성 균의 대사체 분석을 위한 대사체 샘플링 및 처리 방법 |
KR20160141140A (ko) * | 2015-05-28 | 2016-12-08 | 고려대학교 산학협력단 | 대사체 분석을 이용한 베체트병 관절염의 진단방법 |
KR20160148807A (ko) * | 2015-06-16 | 2016-12-27 | 연세대학교 산학협력단 | 장 베체트병 진단용 바이오마커 및 이의 용도 |
Non-Patent Citations (1)
Title |
---|
AHN, JOONG KYONG ET AL.: "A comparative metabolomic evaluation of behcet's d isease with arthritis and seronegative arthritis using synovial fluid", PLOS ONE, 13 January 2015 (2015-01-13), pages e0135856-1 - e0135856-13, XP055679589 * |
Also Published As
Publication number | Publication date |
---|---|
JP7179356B2 (ja) | 2022-11-29 |
JP2020517935A (ja) | 2020-06-18 |
CN110546505A (zh) | 2019-12-06 |
WO2018199530A2 (ko) | 2018-11-01 |
KR20180119717A (ko) | 2018-11-05 |
KR101946884B1 (ko) | 2019-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018199530A3 (ko) | 대사체 분석을 이용한 베체트병의 진단방법 | |
PH12015501744A1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
WO2014160441A8 (en) | Neuroactive steroids, compositions, and uses thereof | |
MX2020010947A (es) | Metodos de tratamiento de enfermedad de alzheimer. | |
MX2018009304A (es) | Metodos de diagnostico y pronostico para episodios y enfermedades cardiovasculares. | |
BR112012020101A2 (pt) | método diagnósticos e terapêuticos usando anticorpos anti-cd200. | |
WO2016184935A3 (en) | Method for evaluating manual dexterity | |
EP3587597A4 (en) | METHOD FOR DIAGNOSING PARKINSON'S DISEASE BY BACTERIOLOGICAL METAGENOME ANALYSIS | |
MY184890A (en) | Improved a? protofibril binding antibodies | |
EA201690213A1 (ru) | Композиции и способ лечения связанных с комплементом состояний | |
EP3285071A4 (en) | Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method | |
NZ703411A (en) | Use of markers in the diagnosis and treatment of prostate cancer | |
WO2015034886A3 (en) | Wellness panel for companion animals | |
MX2015015907A (es) | Metodo no invasivo objetivo para cuantificar el grado de comezon mediante el uso de mediciones psicofisiologicas. | |
NZ729773A (en) | Biomarkers for disease progression in melanoma | |
MX2020009879A (es) | Anticuerpos anti-il-27 y sus usos. | |
WO2015081283A3 (en) | Long non-coding rna as a diagnostic and therapeutic agent | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
WO2014043633A8 (en) | Use of e-cadherin and vimentin for selection of treatment responsive patients | |
MX2021006980A (es) | Anticuerpos anti-il-27 y usos de estos. | |
WO2016012864A3 (en) | Biomarkers for anderson-fabry disease | |
MX2020002462A (es) | Estratificacion de genotipo en tratamiento y prevencion de diabetes. | |
EP3625248A4 (en) | COMPOSITIONS AND METHODS OF DIAGNOSIS AND TREATMENT OF DISEASES AND DISEASES ASSOCIATED WITH KCNJ5 MUTATIONS | |
EP4289970A3 (en) | Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis | |
MX2015017535A (es) | Tratamiento de resistencia a la insulina a traves de inhibidores del factor de transcripcion tsc22d4. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2019557367 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18792329 Country of ref document: EP Kind code of ref document: A2 |